OptimizeRX Shares Surge on Exceptional Quarterly Performance and Upgraded Outlook

OptimizeRX Corporation witnessed a dramatic surge in its share price following the release of an exceptionally strong quarterly earnings report and a significant upward revision to its full-year guidance. The financial results, which substantially exceeded market expectations, prompted immediate positive reactions from analysts and investors alike.

The healthcare technology company announced record-breaking results for the second quarter of 2025. Revenue demonstrated remarkable growth, climbing 55% year-over-year to reach $29.2 million. In a pivotal turnaround for the business, OptimizeRX reported a GAAP net income of $1.5 million, a stark contrast to the net loss recorded during the same period last year.

The market response was swift and decisive. In pre-market trading following the announcement, the company’s stock price jumped 23.05%. Earnings per share Read more...